Skip to main content

Table 2 Effect sizes and confidence intervals for confounders and associated variables

From: Characteristics of salivary cortisol and alpha-amylase as psychobiological study outcomes in palliative care research

Variable

sCort

sAA

Within-session correlation

r = 0,92; CI = (0,82; 0,96); N = 26

r = 0,83; CI = (0,66; 0,92); N = 28

Between-session correlation

r = 0,78; CI = (0,54; 0,90); N = 24

r = 0,68; CI = (0,40; 0,84); N = 26

sAA

r = -0,14; CI = (-0,27; -0,01); N = 221

-

VAS-W

r = -0,18; CI = (-0,31; -0,05); N = 224

r = -0,05; CI = (-0,17; 0,08); N = 233

VAS-S

r = 0,14; CI = (0,26; 0,01); N = 224

r = 0,14; CI = (0,26; 0,01); N = 233

mHR

r = 0,46; CI = (0,34; 0,57); N = 197

r = -0,03; CI = (-0,16; 0,11); N = 204

HFnu

r = -0,32; CI = (-0,44; -0,19); N = 200

r = 0,10; CI = (-0,04; 0,23); N = 207

KPSS

r = -0,39; CI = (-0,66; -0,02); N = 29

r = -0,13; CI = (-0,47; 0,24); N = 30

gQOL

r = -0,47; CI = (-0,71; -0,12); N = 29

r = 0,20; CI = (-0,17; 0,52); N = 30

Age

r = 0,17; CI = (-0,21; 0,50); N = 29

r = 0,05; CI = (-0,32; 0,40); N = 30

Sex

d = 0,22; CI = (-0,49; 0,93); N = 33

d = -0,95; CI = (-1,69; -0,22); N = 35

Time since wake up

r = -0,13; CI = (-0,37; 0,13); N = 58

r = 0,05; CI = (-0,20; 0,30); N = 61

Time since toothbrush

r = 0,31; CI = (0,05; 0,52); N = 57

r = -0,07; CI = (-0,32; 0,19); N = 60

Time since last drink

r = -0,03; CI = (-0,29; 0,24); N = 54

r = 0,18; CI = (-0,09; 0,42); N = 56

Time since last meal

r = 0,39; CI = (0,14; 0,60); N = 55

r = -0,07; CI = (-0,32; 0,19); N = 58

Mouth injuries

d = -0,61; CI = (-1,54; 0,31); N = 58

d = 0,32; CI = (-0,59; 1,24); N = 61

Xerostomia

d = 0,26; CI = (-0,28; 0,81); N = 58

d = 0,02; CI = (-0,52; 0,55); N = 61

Caffeine intake

d = -0,02; CI = (-0,54; 0,50); N = 58

d = -0,13; CI = (-0,64; 0,37); N = 61

Analgesic medication

d = 0,61; CI = (-0,32; 1,53); N = 56

d = -0,07; CI = (-0,99; 0,84); N = 59

Antidepressant medication

d = -0,17; CI = (-0,83; 0,49); N = 56

d = 1,26; CI = (0,56; 1,95); N = 59

Antipsychotic medication

d = -0,66; CI = (-1,31; -0,01); N = 56

d = 0,22; CI = (-0,41; 0,86); N = 59

Cardiovascular medication

d = -0,01; CI = (-0,55; 0,54); N = 56

d = -0,53; CI = (-1,07; 0,02); N = 59

Corticosteroid medication

d = -0,92; CI = (-1,78; -0,05); N = 56

d = -0,15; CI = (-1,00; 0,69); N = 59

Hormonal medication

d = 0,26; CI = (-0,46; 0,97); N = 56

d = -1,42; CI = (-2,15; -0,69); N = 59

Sedative medication

d = 0,75; CI = (-0,11; 1,61); N = 56

d = -0,75; CI = (-1,51; 0,01); N = 59

  1. Notes: sCort salivary cortisol, sAA salivary alpha amylase, VAS-W visual analogue scale – wellbeing, VAS-S visual analogue scale – stress, mHR mean heart rate, HFnu High frequency heart rate variability in normalized units, KPSS Karnofsky Performance Status Scale, gQOL global quality of life (McGill Quality of Life Questionnaire – Revised)